CYP2B6 and vitamin D deficiency: Indeed, a CYP2B6 genotype-based efavirenz dose adjustment was recommended recently to optimize treatment outcomes.[23,24] Implication of inter-individual variations in efavirenz plasma concentration for efavirenz-induced vitamin D deficiency is yet to be investigated.